Insulet Corp. Stock
Price
Target price
€170.45
€170.45
-1.610%
-2.8
-1.610%
€315.54
09.04.26 / Tradegate
WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insulet Corp. Stock
We can see a decrease in the price for Insulet Corp.. Compared to yesterday it has lost -€2.800 (-1.610%).
With 52 Buy predictions and not a single Sell prediction Insulet Corp. is an absolute favorite of our community.
As a result the target price of 315 € shows a very positive potential of 84.8% compared to the current price of 170.45 € for Insulet Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Insulet Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Insulet Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | -1.610% | -3.782% | -17.697% | -29.595% | -30.201% | -41.406% | -29.303% |
| Neogen Corp. | 3.580% | 6.534% | 2.095% | 86.435% | 39.447% | - | - |
| CONMED Corp. | 0.000% | 4.000% | -7.692% | -32.174% | -10.857% | -67.500% | -72.632% |
| Bio-Techne Corp. | 0.960% | 0.519% | -6.747% | 4.126% | -7.120% | -33.180% | - |
Comments
Insulet (PODD) had its price target lowered by The Goldman Sachs Group, Inc. from $326.00 to $277.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (PODD) had its price target lowered by Evercore Inc from $340.00 to $240.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (PODD) had its price target lowered by Citigroup Inc. from $345.00 to $338.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
News
Is Insulet (PODD) the Future of Diabetes Management?
Explore the exciting world of Insulet (NASDAQ: PODD) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market
